Journals / Literatür Eczacılık Bilimleri Dergisi / 2020 / Cilt: 9 - Sayı: 1

CRISPR-Cas9 Technology, Safety and Evaluation from an Ethical Perspective

CRISPR-Cas9 Teknolojisi, Güvenliliği ve Etik Açıdan Değerlendirilmesi

Pages
50–64
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review we will mention the main principles and safety issues of CRISPR-Cas9 technology as well as the ethical concerns and toxicological problems.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Today, a genomic engineering tool “Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)”-Cas9 (CRISPR associated) system has started a new era in biological sciences.
📊
Key Findings & Data:CRISPRCas9 system was first discovered in prokaryotes like bacteria and archaea as an RNA and a protein-based system that protects the cell against bacteriophage infections, invading plasmids and foreign nucleic acids.
💡
Conclusion & Impact:In this review we will mention the main principles and safety issues of CRISPR-Cas9 technology as well as the ethical concerns and toxicological problems.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Today, a genomic engineering tool “Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)”-Cas9 (CRISPR associated) system has started a new era in biological sciences. CRISPRCas9 system was first discovered in prokaryotes like bacteria and archaea as an RNA and a protein-based system that protects the cell against bacteriophage infections, invading plasmids and foreign nucleic acids. The ability of easy and sensitive replacement of DNA sequences, deletion and most of all arrangement have attracted attention of scientists in a wide range of biotechnology study fields including medicine, energy and environment studies. From a medical perspective, this technology can be used in pre-clinical and clinical studies to treat several diseases. Targetable nucleases that enable the scientist to target and change a gene in an organism can pave the way for these treatments. This system is now being used in researches in embryology, cancer, neurological and infectious diseases. However, problems have not solved for the safety issues of CRISPR-Cas9 system. In addition, ethical concerns are still continuing for the use of this system in several fields, particularly in human embryos. In this review we will mention the main principles and safety issues of CRISPR-Cas9 technology as well as the ethical concerns and toxicological problems.

Özet

Günümüzde bir genom mühendisliği aracı olan “Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)”-Cas9 (CRISPR associated) sistemi, biyolojik bilimlerde yepyeni bir dönem başlatmıştır. CRISPR-Cas9 sistemi; ilk olarak bakteri ve arkealar gibi prokaryotlarda keşfedilen, bakteriyofaj enfeksiyonları, istilacı plazmidler ve yabancı nükleik asitlere karşı hücreyi korumayı amaçlayan RNA ve protein tabanlı bir sistemdir. DNA sekanslarını kolayca ve hassas bir şekilde yerleştirme, çıkarma ve hatta düzenleme yeteneği, tıp, enerji ve hatta çevre çalışmaları gibi geniş bir yelpazedeki biyoteknoloji alanlarında bilim çevrelerinin ilgisini çekmektedir. Tıbbi açıdan bakıldığında bu teknoloji, klinik öncesi ve klinik çalışmalarla çeşitli hastalıkların tedavisinde kullanılabilir. Bilim adamlarının herhangi bir organizmada herhangi bir geni teorik olarak hedeflemesine ve değiştirmesine olanak sağlayan hedeflenebilir nükleazlar, bu tedavilerin yolunu açmaktadır. Bu sistem embriyoloji, kanser, nörolojik hastalıklar ve enfeksiyon hastalıklarında araştırma aşamasında kullanıma girmiştir. Ancak CRISPRCas9 sisteminin güvenliği ile ilgili konular henüz çözülememiştir. Ayrıca, bu sistemin başta insan embriyolarında kullanımı olmak üzere birçok alanda kullanımı üzerine etik kaygılar devam etmektedir. Bu derleme kapsamında CRISPR-Cas9 teknolojisinin dayandığı prensiplerden ve bu teknolojinin güvenliğinden söz edilecek; sistemin kullanımı ile ortaya çıkabilecek etik kaygılar irdelenecektir.

🔖

Cite This Article

KÖSE, S., SUR, Ü., YİRÜN, A., BALCI, A., GÜMÜŞEL, B., ERKEKOĞLU, P. (2020). CRISPR-Cas9 Technology, Safety and Evaluation from an Ethical Perspective. Literatür Eczacılık Bilimleri Dergisi, Cilt: 9 - Sayı: 1, 50–64. https://ajindex.com/articles/274569

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Doudna JA, Charpentier E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science. 2014
  2. 346(6213): 1258096. [Crossref] [PubMed] 2. Chen S, Yu X, Guo D. CRISPR-cas targeting of host genes as an antiviral strategy. Viruses. 2018
  3. 10(1).pii: E40. [Crossref] [PubMed] [PMC] 3. Cao J, Xiao Q, Yan Q. The multiplexed CRISPR targeting platforms. Drug Discov Today Technol. 2018
  4. [Crossref] [PubMed] [PMC] 4. Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science. 2007
  5. 315(5819):1709-12. [Crossref] [PubMed] 5. Provasi E, Genovese P, Lombardo A, Magnani Z, Liu PQ, Reik A, et al. Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer. Nat Med. 2012
  6. 18(5):807-15. [Crossref] [PubMed] [PMC] 6. Segal DJ, Meckler JF. Genome engineering at the dawn of the golden age. Annu Rev Genomics Hum Genet. 2013
  7. [Crossref] [PubMed] 7. Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013
  8. 8(11):2281-308. [Crossref] [PubMed] [PMC] 8. Ishino Y, Shinagawa H, Makino K, Amemura M, Nakata A. Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J Bacteriol. 1987
  9. 169(12):5429-33. [Crossref] [PubMed] [PMC] 9. Bolotin A, Quinquis B, Sorokin A, Ehrlich SD. Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology. 2005
  10. 151(Pt 8):2551-61. [Crossref] [PubMed] 10. Mojica FJ, Díez-Villaseñor C, García-Martínez J, Soria E. Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J Mol Evol. 2005
  11. 60(2):174- 82. [Crossref] [PubMed] 11. Pourcel C, Salvignol G, Vergnaud G. CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiology. 2005
  12. 151(Pt 3):653-63. [Crossref] [PubMed] 12. Horvath P, Barrangou R. CRISPR/Cas, the immune system of bacteria and archaea. Science. 2010
  13. 327(5962):167-70. [Crossref] [PubMed] 13. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012
  14. 337(6096):816-21. [Crossref] [PubMed] [PMC] 14. Cong L, Ran FA, Cox D, Lin S,